title: Clinical trial transparency--antidote to weaker off-label-promotion rules?
authors.affiliation: From Boston University School of Law, Boston.
authors.forename: Kevin
authors.initials: K
authors.lastname: Outterson
mesh_terms: D002961:Civil Rights; D002986:Clinical Trials as Topic / Q000592:standards*; D004345:Drug Industry / Q000191:economics / Q000331:legislation & jurisprudence*; D004348:Drug Labeling / Q000331:legislation & jurisprudence; D033161:Government Regulation; D006801:Humans; D033181:Information Dissemination / Q000331:legislation & jurisprudence; D040541:Marketing / Q000331:legislation & jurisprudence; D056687:Off-Label Use / Q000331:legislation & jurisprudence*; D014481:United States; D014486:United States Food and Drug Administration